Activity Dates: 01/13/2016 - 11/10/2016
This activity has been developed and designed for pharmacists who are preparing to sit for the Board of Pharmacy Specialty (BPS) exam in Psychiatric Pharmacy as they strive to obtain the credentials of Board Certified Psychiatric Pharmacist (BCPP).
This NEW BCPP prep product includes 11 recorded review webinars and a series of question and answer sessions with authors/presenters immediately before the spring and fall testing windows.
The recorded webinar presentations are structured to provide a review of the major topics in the psychiatric pharmacy domains as specified by the BCPP Specialty Council in the current edition of the BPS Candidate's Guide. Authors provide an overview of key topics as aligned with the BCPP content outline. Webinars feature vignette-based self-assessment questions with feedback. To obtain optimal benefit, the participant should also purchase the Psychiatric Pharmacotherapy Review Book (check out the bundle cost savings) and have reviewed the chapter for the specified disease state before listening to the recorded presentation. The presenter will be referring the participant back to the chapter for complete details on some items.
Six, 1-hour calls/webinars will be delivered by authors of the 2016 Psychiatric Pharmacotherapy Review chapters in the 6 weeks leading up the spring and fall testing windows. Participants will have the opportunity to pose questions online the week prior to the call and during the call. The webinars will be posted online within one week following the live date.
| Topic | Speaker | Moderator | Date: Thursdays |
|---|---|---|---|
| Anxiety and Anxiety-Related Disorders | Sarah Melton | Chris Paxos | 8/11 |
| Sleep-Wake Disorders | Ericka Breden Crouse | Chris Paxos | 8/11 |
| Bipolar Disorder | Jonathan Leung | Megan Ehret | 8/18 |
| Depression | Cynthia Gutierrez | Megan Ehret | 8/18 |
| Personality Disorders and Eating Disorders | Kelly Gable | Ben Chavez | 8/25 |
| Neurocognitive Disorders | Christopher Thomas | Ben Chavez | 8/25 |
| Neurologic Disorders | Kimberly Tallian | Rex Lott | 9/1 |
| Neurodevelopmental, Disruptive, Impulse-Control and Conduct Disorders | Sandra Mullen | Rex Lott | 9/1 |
| Schizophrenia Spectrum and Other Psychotic Disorders | Lisa Goldstone | Carol Ott | 9/8 |
| Substance-Related Disorders | Calleen Lavinghousez | Megan Ehret | 9/15 |
| Biostatistics and Research Design in Psychiatry | Ryan Carnahan | Megan Ehret | 9/15 |
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 7 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
|
Ericka L. Breden Crouse, PharmD, BCPP, CGP, FASCP, FASHP
Clinical Pharmacy Specialist – Psychiatry No Relevant Financial Relationships to Disclose |
|
Kelly N. Gable, PharmD, BCPP
Associate Professor No Relevant Financial Relationships to Disclose |
|
Lisa W. Goldstone, PharmD, MS, BCPS, BCPP
Assistant Professor, Department of Pharmacy Practice and Science No Relevant Financial Relationships to Disclose |
|
Cynthia A. Gutierrez, PharmD, MS, BCPP Clinical Pharmacy Specialist, Psychiatry
South Texas Veterans Health Care System Clinical Assistant Professor The University of Texas College of Pharmacy, Austin, Texas And The University of Texas Health Science Center at San Antonio San Antonio, Texas No Relevant Financial Relationships to Disclose |
|
Calleen Lavinghousez, PharmD, BCPS, BCPP
Clinical Specialist, Mental Health No Relevant Financial Relationships to Disclose |
|
Jonathan G. Leung, PharmD, BCPS, BCPP
Psychiatric Clinical Pharmacist No Relevant Financial Relationships to Disclose |
|
Sarah T. Melton, PharmD, BCPP, CGP, FASCP, BCACP
Associate Professor of Pharmacy Practice No Relevant Financial Relationships to Disclose |
|
Sandra Mullen, PharmD, BCPP
Clinical Pharmacist – Psychiatry No Relevant Financial Relationships to Disclose |
|
Kimberly Tallian, PharmD, BCPP, FASHP, FCCP, FCSHP
Psychiatry Pharmacy Specialist, Scripps Mercy Hospital, San Diego/ Director of the Residency & Teaching Certificate Program, Adjunct Professor of Clinical Sciences, Professor; Keck Graduate Institute, School of Pharmacy – Claremont Colleges No Relevant Financial Relationships to Disclose |
|
Christopher Thomas, PharmD, BCPP, BCPS
Director, ASHP Accredited PGY-1 and PGY-2 (Psychiatry) Residency Programs Clinical Associate Professor of Pharmacology Stock Disclosure: Merck, Pfizer, Lilly |
2016 Review Course Editorial Board
Disclosures of Interest
|
Benjamin Chavez, PharmD, BCPP Aurora, CO No Relevant Financial Relationships to Disclose |
Megan J. Ehret, PharmD, MS, BCPP |
Robert J. Haight, PharmD, BCPP |
Cynthia K. Kirkwood, PharmD, BCPP |
Rex S. Lott, PharmD, BCPP |
|
Carol A. Ott, PharmD, BCPP Indianapolis, IN Non-Financial Interests: Indiana Medicaid Drug Utilization Review (DUR) Board, MHA-Tippecanoe (Indiana County) Board of Directors, Indiana Medicaid Mental Health Quality Advisory Committee (MHQAC), Primary Care Psychiatry Foundation Board of Directors Consultant: Indiana University Child Psychiatry/Department of Child Services, Indiana; Indiana Attorney General's Office; PSAP chapter author |
|
Chris Paxos, PharmD, BCPP, BCPS, CGP Rootstown, OH No Relevant Financial Relationships to Disclose |
Shannon N. Saldana, PharmD, MS, BCPP |
|
Mark D. Watanabe, PharmD, BCPP, PhD Denver, CO Employment: Northeastern University, Assistant Clinical Professor of Pharmacy Practice |
|
Jennifer L. Zacher, PharmD, BCPP Hines, IL No Relevant Financial Relationships to Disclose |
2016 Psychiatric Pharmacotherapy Review Peer Reviewers
Disclosures of Interest
Saadia Ali, PharmD |
Kristen Allison, PharmD, BCPP, BCPS |
Jacquelyn Canning, PharmD, BCPP |
Lauren Diefenderfer, PharmD, BCPP |
Clayton D. English, PharmD, BCPP, BCPS |
Shauna S. Garris, PharmD, BCPP, BCPS |
Margaret Haberman, PharmD, BCPP |
Robin N. Hieber, PharmD, BCPP |
Karrie R. Jones, PharmD, BCPP, BCPS |
Megan Maroney, PharmD, BCPP |
Marketa Marvanova, PharmD, MS, BCPP, CGP, PhD |
Meghan M. Norris, PharmD, BCPP, BCPS |
Emma C. Palmer, PharmD, BCPS, BCPP |
Stephanie V. Phan, PharmD, BCPP |
Michael D. Shuman, PharmD, BCPP |
Michele D. Thomas, PharmD, BCPP |
John R. Tomko, PharmD, BCPP |
Ruki Wijesinghe, PharmD, BCPP |
Kelly E. Williams, PharmD, BCPP |
Todd J. Woodard, PharmD, BCPP, BCPS, CGP |
All relevant relationships have been mitigated.
2016 Medication Table Authors/Editors
Disclosures of Interest
Shari N. Allen, PharmD, BCPP |
|
Elayne D. Ansara, PharmD, BCPP, BCPS Clinical Pharmacy Specialist Eskenazi Health Indianapolis, IN External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: spouse is speaker for Astra Zeneca (product: ticagrelor), Boehringer Ingelheim (products: dabigatran and idarucizumab), Bristol Myers Squibb (product: apixaban), and Daiichi Sankyo, Inc. (product: edoxaban) Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: None |
Catherine Floroff, PharmD |
|
Lisa W. Goldstone, MS, PharmD, BCPS, BCPP Assistant Professor University of Arizona College of Pharmacy Tucson, AZ Employment: The University of Arizona, Assistant Professor Banner University Medical Center - South, Assistant Professor/Psychiatric Pharmacist Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: None |
|
Jacob T. Held, PharmD, BCPP Clinical Pharmacy Specialist--Psychiatry Regions Hospital Minneapolis, MN No Relevant Financial Relationships to Disclose Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: None |
Robin N. Hieber, PharmD, BCPP |
Jennifer Kelly, PharmD, MSPharm, MBA, BCPS |
|
Calleen Lavinghousez, PharmD, BCPP, BCPS Clinical Specialist, Psychiatry Ralph H. Johnson VAMC Charleston, SC No Relevant Financial Relationships to Disclose Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: None |
|
Mei T. Liu, PharmD, BCPP Clinical Assistant Professor Rutgers University Princeton, NJ No Relevant Financial Relationships to Disclose Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: None |
Shruti Lopchuk, PharmD, BCPP |
Talia Puzantian, PharmD, BCPP |
|
Tara Reddy, PharmD, BCPP Clinical Pharmacist VA Sierra Nevada Healthcare System Reno, NV Employment: VA Sierra Nevada Health Care System, Clinical Pharmacy Specialist Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: None |
|
Sophie Robert, PharmD, BCPP Clinical Pharmacy Specialist, Psychiatry Medical University of South Carolina Charleston, SC No Relevant Financial Relationships to Disclose Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: None |
|
Amy M. VandenBerg, PharmD, BCPP Medical University of South Carolina Charleston, SC No Relevant Financial Relationships to Disclose Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: None |
|
Dorothy Williams, PharmD, BCPP Clinical Psychiatric Pharmacist Shawnee Mission Medical Center Shawnee Mission, KS No Relevant Financial Relationships to Disclose My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices. Please indicate drugs and/or devices here: None |
Kara R. Wong, PharmD, BCPP |
All relevant relationships have been mitigated.
This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), or are currently investigational.
In accordance with the Food and Drug Administration (FDA), it is disclosed that there is the potential for discussions concerning off-label uses of a commercial product/devices during this educational activity.
Any person who may contribute to the content of this continuing education activity must disclose significant relationships (and any known relationships of their spouse/partner) with commercial companies whose products or services are discussed in this activity. Significant relationships include receiving from a commercial company research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.
Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.
